Clicks GroupJSE:CLS +1.93%85 Days Payable is 97.19 as of Feb. 2026, which is 23% above its 10-year median of 78.75. GuruFocus rates JSE:CLS with a GF Score™ of 85/100 and a GF Value™ of R385.29 (Significantly Undervalued). Among 607 Healthcare Providers & Services companies, Clicks Group ranks better than 68.37% on this metric.
The historical rank and industry rank for Clicks Group's Days Payable or its related term are showing as below:
JSE:CLS'
s Days Payable Range Over the Past 10 Years
Min: 73.49 Med: 78.75 Max: 96.39
Current: 96.39
During the past 13 years, Clicks Group's highest Days Payable was 96.39. The lowest was 73.49. And the median was 78.75.
JSE:CLS's Days Payable is ranked better than 68.37% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 58
vs JSE:CLS: 96.39
Clicks Group's Days Payable
increased
from Feb. 2025 (89.99) to Feb. 2026 (97.19).
It may suggest that Clicks Groupdelayed paying its suppliers.
Clicks Group Days Payable Related Terms
Clicks Group Days Payable Historical Data
* Premium members only.
The historical data trend for Clicks Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Clicks Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clicks Group Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clicks Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Clicks Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Clicks Group's Days Payable for the fiscal year that ended in Aug. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clicks Group (JSE:CLS) has a Days Payable of 97.19 as of Feb. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Clicks Group and its competitors. This is 23% above median its historical median of 78.75. Over the past decade, Clicks Group's Days Payable has ranged from 73.49 to 96.39. According to the industry distribution chart, Clicks Group ranks #192 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 31.6%.
Is Clicks Group's Days Payable too high?
Clicks Group's current Days Payable of 97.19 is 23% above median its 10-year median of 78.75. Over the past 10 years, this metric has ranged from a low of 73.49 to a high of 96.39. The Healthcare Providers & Services industry median Days Payable is 58.00. Clicks Group's value of 97.19 is 67.6% above this industry median. Based on the distribution chart, Clicks Group ranks #192 out of 607 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Clicks Group has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Clicks Group's Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Clicks Group ranks #192 out of 607 companies for Days Payable. This puts Clicks Group in the upper half of its industry. The industry median Days Payable is 58.00. Clicks Group's value of 97.19 is 67.6% above this benchmark. Historically, Clicks Group's own Days Payable has ranged from 73.49 to 96.39 over the past decade. While the company's 10-year median is 78.75 vs. the industry median of 58.00, Clicks Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.00, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clicks Group's current Days Payable of 97.19 is 67.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Clicks Group and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clicks Group's current Days Payable is 97.19, which is 23% above median its own 10-year median of 78.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clicks Group stock overvalued right now?
Based on GuruFocus' analysis, Clicks Group (JSE:CLS) is currently considered Significantly Undervalued. The stock's GF Value™ is R385.29, compared to a current price of R231.85 — trading 39.8% below its estimated fair value. The current Days Payable is 97.19, which is 23% above median its 10-year median of 78.75 and 67.6% above the Healthcare Providers & Services industry median of 58.00. Clicks Group's overall GF Score™ is 85/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Clicks Group (JSE:CLS), the current Days Payable is 97.19 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clicks Group (JSE:CLS) Overvalued in 2026?
Based on GuruFocus' analysis, Clicks Group stock appears to be undervalued.
The current stock price of R231.85 is trading 39.8% below its estimated GF Value™ of R385.29.
GuruFocus considers Clicks Group to be Significantly Undervalued.
Key valuation signals for JSE:CLS:
Days Payable: 97.19 (23% above median its 10-year median of 78.75)
GF Value™: R385.29 vs. price of R231.85 (39.8% below fair value)
Industry Position: 67.6% above the Healthcare Providers & Services median (#192 of 607)
No single metric tells the full story. See the JSE:CLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clicks Group Ltd operates prominently in health, beauty, and wellness retail across southern Africa. The company predominantly operates a retail pharmacy chain in South Africa, with a limited number of operations in bordering countries. The company has a portfolio of retail franchise brands including The Body Shop, M-Kem, and Sorbet among others. The company's business segments include Retail and Distribution. The company generates revenue from in-store and online sales of health, beauty, and wellness items, plus wholesale pharmaceutical distribution. Geographically, the maximum revenue is generated from South Africa.
85GF Score
Get the complete analysis for JSE:CLS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:CLS has been successfully added to your 
